Antoni Ribas
Net worth: 2 M $ as of 30/06/2026
Net worth: 2 M $ as of 30/06/2026
Antoni Ribas is the founder of Tango Therapeutics Sub, Inc. founded in 2017, Tango Therapeutics, Inc. founded in 2017, Kalthera, Inc. founded in 2021, and Lutris Pharma Ltd. founded in 2015 where Dr. Ribas holds the title of Chairman since 2022.
Dr. Ribas was also the founder of Kite Pharma, Inc.,Flexus Biosciences, Inc.,PACT Pharma, Inc...
Dr. Ribas previously served as Director-Tumor Immunology Program at Jonsson Comprehensive Cancer Center, Independent Director at Arcus Biosciences, Inc. since 2019, Professor-Medicine, Surgery & Molecular at the University of California, Los Angeles, Venture Partner at Ysios Capital Partners SGEIC SA since 2020, and Professor at the University of California.
Former positions include Director at The Parker Institute For Cancer Immunotherapy and President-Elect at the American Association for Cancer Research.
Education includes doctorates conferred in 1990 and 1997 from the University of Barcelona.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 11/06/2026 | 52,853 ( 0.04% ) | 2 M $ | 30/06/2026 |
| Companies | Position | Start |
|---|---|---|
| ARCUS BIOSCIENCES, INC. | Director/Board Member | 28/10/2019 |
University of California
University of California Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center Medical/Nursing ServicesHealth Services Part of University of California, Jonsson Comprehensive Cancer Center is a multidisciplinary cancer center that integrates basic, translational, and clinical research to advance personalized cancer care across all stages of treatment. The company is based in Los Angeles, CA. The center offers comprehensive services including prevention, early detection, precision diagnostics, innovative therapies, survivorship support, and access to clinical trials. It specializes in a wide range of cancers such as breast, prostate, lung, colorectal, kidney, and sarcoma, and provides targeted treatments and immunotherapies. Research is organized into interdisciplinary programs focusing on cancer stem cell biology, immunotherapy, molecular imaging, and gene regulation. The center manages clinical trial infrastructure, supports education and training for trainees and faculty, and conducts cancer prevention and control research with community outreach. Philanthropy supports research, clinical trials, and patient services, including integrative oncology programs. The center provides language and disability access services and fosters a patient-centered environment. | Corporate Officer/Principal | - |
University of California, Los Angeles
University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Lutris Pharma Ltd.
Lutris Pharma Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that improves anti cancer therapy effectiveness | Founder | 14/12/2015 |
Ysios Capital Partners SGEIC SA
Ysios Capital Partners SGEIC SA Investment ManagersFinance Ysios Capital invests in companies located across the globe. The firm targets companies operating in the fields of the biotechnology sector. It provides financing for early and growth stage capital requirements. | Private Equity Investor | 01/06/2020 |
| Companies | Position | End |
|---|---|---|
Kalthera, Inc.
Kalthera, Inc. Miscellaneous Commercial ServicesCommercial Services Provides progressive clinical trials services | Founder | 02/01/2021 |
The Parker Institute For Cancer Immunotherapy
The Parker Institute For Cancer Immunotherapy Miscellaneous Commercial ServicesCommercial Services Operates cancer research | Director/Board Member | - |
| TANGO THERAPEUTICS, INC. | Founder | - |
| ░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░ | - |
| ░░░░ ░░░░░░ ░░░ | ░░░░░░░ | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 15 |
|---|---|
University of California, Los Angeles
University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Barcelona
University of Barcelona Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Association for Cancer Research
American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services Engages in research, education, communication and collaboration to prevent and cure cancer | Commercial Services |
Ysios Capital Partners SGEIC SA
Ysios Capital Partners SGEIC SA Investment ManagersFinance Ysios Capital invests in companies located across the globe. The firm targets companies operating in the fields of the biotechnology sector. It provides financing for early and growth stage capital requirements. | Finance |
Kite Pharma, Inc.
Kite Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company which engages in the development of novel cancer immunotherapeutic products | Health Technology |
Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center Medical/Nursing ServicesHealth Services Part of University of California, Jonsson Comprehensive Cancer Center is a multidisciplinary cancer center that integrates basic, translational, and clinical research to advance personalized cancer care across all stages of treatment. The company is based in Los Angeles, CA. The center offers comprehensive services including prevention, early detection, precision diagnostics, innovative therapies, survivorship support, and access to clinical trials. It specializes in a wide range of cancers such as breast, prostate, lung, colorectal, kidney, and sarcoma, and provides targeted treatments and immunotherapies. Research is organized into interdisciplinary programs focusing on cancer stem cell biology, immunotherapy, molecular imaging, and gene regulation. The center manages clinical trial infrastructure, supports education and training for trainees and faculty, and conducts cancer prevention and control research with community outreach. Philanthropy supports research, clinical trials, and patient services, including integrative oncology programs. The center provides language and disability access services and fosters a patient-centered environment. | Health Services |
University of California
University of California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Flexus Biosciences, Inc.
Flexus Biosciences, Inc. BiotechnologyHealth Technology Provides cancer therapeutics through innovative apps | Health Technology |
Arcus Biosciences, Inc.
Arcus Biosciences, Inc. BiotechnologyHealth Technology Develops and commercializes novel therapies for the treatment of lung & gastrointestinal cancers | Health Technology |
Tango Therapeutics Sub, Inc.
Tango Therapeutics Sub, Inc. BiotechnologyHealth Technology Develops transformational new drugs for cancer patients | Health Technology |
The Parker Institute For Cancer Immunotherapy
The Parker Institute For Cancer Immunotherapy Miscellaneous Commercial ServicesCommercial Services Operates cancer research | Commercial Services |
PACT Pharma, Inc.
PACT Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Lutris Pharma Ltd.
Lutris Pharma Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that improves anti cancer therapy effectiveness | Health Technology |
Tango Therapeutics, Inc.
Tango Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company that engages in discovering and delivering precision cancer medicines | Health Technology |
Kalthera, Inc.
Kalthera, Inc. Miscellaneous Commercial ServicesCommercial Services Provides progressive clinical trials services | Commercial Services |
Select your edition
All financial news and data tailored to specific country editions